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Abstract
Background: Accurate prediction of delirium in the intensive care unit (ICU) may facilitate efficient use of early
preventive strategies and stratification of ICU patients by delirium risk in clinical research, but the optimal delirium
prediction model to use is unclear. We compared the predictive performance and user convenience of the
prediction model for delirium (PRE-DELIRIC) and early prediction model for delirium (E-PRE-DELIRIC) in ICU patients
and determined the value of a two-stage calculation.
Methods: This 7-country, 11-hospital, prospective cohort study evaluated consecutive adults admitted to the ICU
who could be reliably assessed for delirium using the Confusion Assessment Method-ICU or the Intensive Care
Delirium Screening Checklist. The predictive performance of the models was measured using the area under the
receiver operating characteristic curve. Calibration was assessed graphically. A physician questionnaire evaluated
user convenience. For the two-stage calculation we used E-PRE-DELIRIC immediately after ICU admission and
updated the prediction using PRE-DELIRIC after 24 h.
Results: In total 2178 patients were included. The area under the receiver operating characteristic curve was
significantly greater for PRE-DELIRIC (0.74 (95% confidence interval 0.71–0.76)) compared to E-PRE-DELIRIC (0.68 (95%
confidence interval 0.66–0.71)) (z score of − 2.73 (p < 0.01)). Both models were well-calibrated. The sensitivity improved
when using the two-stage calculation in low-risk patients. Compared to PRE-DELIRIC, ICU physicians (n = 68) rated the
E-PRE-DELIRIC model more feasible.
Conclusions: While both ICU delirium prediction models have moderate-to-good performance, the PRE-DELIRIC model
predicts delirium better. However, ICU physicians rated the user convenience of E-PRE-DELIRIC superior to PRE-DELIRIC. In
low-risk patients the delirium prediction further improves after an update with the PRE-DELIRIC model after 24 h.
Trial registration: ClinicalTrials.gov, NCT02518646. Registered on 21 July 2015.
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Background
Delirium, defined as acute brain dysfunction featured by
disturbances of attention, awareness, and cognition with
a fluctuating course caused by an underlying medical
condition [1], occurs frequently in the intensive care unit
(ICU), is associated with impaired patient outcome, and
substantially increases healthcare costs [2, 3]. Given
these deleterious consequences, delirium prevention is
crucial.
Delirium preventive measures are important for all ICU
patients. However, a delirium prediction model may facili-
tate early recognition of the patients who may benefit the
most from delirium prevention [4]. In the case of limited
resources, non-pharmacologic reduction strategies and
medication-based strategies may be most relevant for pa-
tients who have an increased risk of developing delirium.
Prediction models may aid clinical decision making and
setting of priorities regarding the use of delirium prevent-
ive measures. For instance, when deciding which patient
should be admitted to the available room with adequate
natural daylight and which patient to the room without it,
preferably the patient with the highest delirium risk
should be admitted to the room with adequate natural
daylight. Also, the use of a delirium prediction model fa-
cilitates patient selection for studies on delirium preven-
tion, which is not only efficient in terms of reducing
waste, but it may also increase the chance of finding an
effect, which ultimately might improve ICU patients’
outcomes. Furthermore, family members can be informed
about the patient’s risk of developing delirium and be
engaged to help provide strategies to reduce delirium
(e.g. cognitive activities) [5]. Involvement of family in pa-
tient care in the ICU is stimulated by many ICU societies
worldwide [6, 7] and might even increase the prevalence
of interventions for delirium prevention and treatment in
the ICU [8].
Two delirium prediction models have been validated
for use in critically ill adults admitted to the ICU [9–11].
The prediction model for delirium in ICU patients
(PRE-DELIRIC model) was developed and validated in a
large cohort of Dutch ICU patients [9]. This model,
which was recently recalibrated in a multinational co-
hort [10], reliably predicts ICU patients’ risk of delirium
using ten predictors obtained within the first 24 h of
ICU admission [10]. However, given that up to 25% of
critically ill adults develop delirium within the first 24 h
of ICU admission [12, 13], and delirium prevention
strategies should be deployed as early as possible, an
early prediction model (E-PRE-DELIRIC) was developed
to predict the risk of delirium the moment a patient is
admitted to the ICU [11]. This E-PRE-DELIRIC model
was developed and validated in a multinational cohort
and uses nine predictors to predict ICU patients’ risk of
delirium [11].
It remains unclear which ICU delirium prediction
model might be recommended for daily clinical practice,
because the comparative predictive performance of the
PRE-DELIRIC and the E-PRE-DELIRIC models and cli-
nicians’ preferences have not been assessed [14]. There-
fore, the objective of this study was to compare the
predictive performance and user convenience of the
PRE-DELIRIC and E-PRE-DELRIC models. Second, we
sought to determine the value of the use of both models
in a two-stage calculation of patients’ risk of delirium in
the ICU (i.e. the E-PRE-DELIRIC model immediately
after ICU admission with an updated delirium risk score
after 24 h of ICU admission using the PRE-DELIRIC
model) to see if we could expand on current models,
since it is well-known that dynamic variables assessed
over time as opposed to variables assessed at admission
only tend to perform better in prediction models.
Methods
Design and study population
The “Delirium prediction in the intensive care unit:
comparison of two delirium prediction models” (DECI-
SION) study was a multinational prospective cohort
study conducted in 11 ICUs from seven different coun-
tries (Australia, Belgium, Canada, Denmark, Portugal,
USA, and the Netherlands). Each study site had a well-
established delirium screening protocol and similar delir-
ium treatment practices. All consecutive, critically ill
adults admitted to the ICU were enrolled. Patients were
excluded if they had delirium at the time of ICU admis-
sion, were discharged from the ICU within 6 h, or were
unable to be reliably assessed for delirium (e.g. sustained
coma, inability to understand the predominant language
spoken in the ICU, severe cognitive dysfunction, re-
ceptive aphasia, or serious auditory or visual disorders)
[9–11]. Each institution enrolled patients for up to three
months or until data on 300 patients were collected.
Data collection
Data were collected over the first 14 days of the ICU
stay. Data for each delirium predictor (nine predictors
for the E-PRE-DELIRIC model and ten for the PRE-
DELIRIC model) were collected in consecutive patients
immediately after ICU admission (E-PRE-DELIRIC) [11]
and within 24 h of ICU admission (PRE-DELIRIC) [9, 10]
and entered into a validated web-based, data management
system, Castor [15]. Severity of illness was estimated at ICU
admission using the Acute Physiology and Chronic Health
Evaluation (APACHE) II score [16] and daily using the
Sequential Organ Failure Assessment (SOFA) score [17].
The presence of delirium in the ICU was evaluated at
least every 12 h by the trained bedside nurse using either
the Confusion Assessment Method for the Intensive
Care Unit (CAM-ICU) [18] or the Intensive Care
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Delirium Screening Checklist (ICDSC) [19]. Develop-
ment of delirium in the ICU was defined as at least one
positive assessment of delirium using the CAM-ICU or
ICDSC. Patients were also deemed to have delirium
whenever they were administered haloperidol or an
atypical antipsychotic drug for treatment of delirium, to
prevent false negative delirium screenings. To eliminate
bias, nurses were kept unaware of the fact that their de-
lirium assessments were used for a study [20].
Level of sedation (using either the Richmond
Agitation-Sedation Scale (RASS) or the Riker Sedation-
Agitation Scale (SAS) [21, 22], and current intravenous
(IV) sedative therapy was documented at the time each
delirium assessment was completed. Delirium was pref-
erentially evaluated when patients were maximally awake
(e.g. after a spontaneous awakening trial). When coma
was present (i.e., RASS = − 4 or − 5 or Riker-SAS = 1 or 2)
patients were designated as unable to be assessed for
delirium.
To help ensure that the nurse delirium assessments
were of high quality [23], a trained investigator (or re-
search nurse) independently and sequentially evaluated
patients for the presence of delirium using the same tool
as the bedside nurse (i.e., CAM-ICU or ICDSC) during
one daytime shift each month and nurse-expert inter-
rater reliability (IRR) was calculated. A delirium assess-
ment compliance rate (i.e. delirium assessments docu-
mented/delirium assessments that should have been
completed) was calculated for one day monthly in each
ICU. If Cohen’s kappa for the paired delirium assess-
ments was ≥ 0.80 and delirium screening compliance
was ≥ 80% then the delirium assessment was considered
to be reliable in that ICU. Prior to the study it was deter-
mined that centres would be described separately if they
did not meet these two reliability criteria and if they had
outcomes that significantly affected the performance of
the (E)-PRE-DELIRIC model in the primary analysis.
Evaluation of the user convenience of the delirium
prediction model
To estimate delirium model user convenience, the prefer-
ences of ICU physicians regarding the two delirium predic-
tion models was determined by electronically administering
a short, optional, and anonymous web-based survey (com-
prising four 5-point, Likert-scale questions) to all physicians
working in each study ICU (Additional file 1). A completed
questionnaire indicated that a physician provided consent
for their data to be used.
Statistical analysis
For each delirium prediction model at least 200 events,
i.e. positive delirium assessments, were needed [24].
With an anticipated delirium incidence conservatively
set at 20%, we aimed to enrol 2000 patients in total
(400/0.20 = 2000 patients).
The discriminative power of both models was assessed
using the area under the receiver-operating characteris-
tic curve (AUROC) [20]. The database was divided into
groups based on the quartiles of the predicted probabil-
ities for delirium development: very low (0.00–0.10), low
(0.10–0.20), moderate (0.20–0.30), and high risk of delir-
ium (≥ 0.30).
Sensitivity, specificity, and likelihood ratios were calcu-
lated for these four groups. Calibration was assessed
graphically by plotting the observed outcome frequen-
cies against the mean predicted outcome probabilities or
risks, within subgroups of patients that were ranked by
increasing estimated probability [25]. The predictive per-
formance of both models was compared using the Han-
ley and McNeil method [26]. It is estimated that
approximately a third of patients will develop delirium
in the ICU [3]. We therefore rated patients with a pre-
dicted probability of delirium <0.30 as low-risk patients
and with probability ≥0.30 as high-risk patients. The
additional value of a two-stage calculation in low-risk
patients was determined using the E-PRE-DELIRIC
model to calculate a patient’s risk of delirium imm-
ediately after ICU admission. Subsequently we used data
from the first 24 h in ICU to update the prediction using
the PRE-DELIRIC model to determine how many pa-
tients with a probability of delirium <0.30 predicted
using the E-PRE-DELIRIC model would subsequently be
labelled at high risk of developing delirium using the
PRE-DELIRIC score. Both risk calculations were com-
pared to the patients’ delirium outcome.
The questionnaires for ICU physicians were analyzed
using the Wilcoxon signed ranks test for non-parametric
statistical testing of two dependent samples. Statistical
significance was defined as p < 0.05 and the null hypoth-
eses were tested against two-sided alternatives. Data
were analysed using SPSS® Statistics version 22 and R
statistics R3.2.4 [27].
Results
A total of 2802 patients were screened for inclusion;
2178 patients (78%) were included. Among the 624 pa-
tients excluded, inability to reliably assess for delirium
(46.3% (289/624)) and delirium at the time of ICU ad-
mission (25.9% (162/624)) were the most common rea-
sons for exclusion (see study flowchart, Fig. 1). Among
the 83 patients that were excluded for other reasons the
most common reasons were severe neurological injury
and confidential files. Patients were 62.1 ± 15.2 years old,
60.8% male, and had a baseline APACHE-II score of 17.
4 ± 7.1. During their ICU stay 21.4% of patients (467/
2178) developed delirium. Patient characteristics are
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presented in Table 1. For patient and hospital characteris-
tics per participating ICU see Additional file 2: Table S1.
Model performance
The AUROC of the PRE-DELIRIC model (0.74 (95% CI
0.71–0.76)) was significantly greater than that for the E-
PRE-DELIRIC model (0.68 (95% CI 0.66–0.71)) (z score
of − 2.73 (p < 0.01)) (Fig. 2). Both models were well-
calibrated (Fig. 3).
At a cutoff of 0.214, the incidence of delirium was 21.
4% in the total sample, and the sensitivity and specificity
were 60 and 65%, respectively, for the E-PRE-DELIRIC
model and 69 and 66% for the PRE-DELIRIC model.
Two-stage calculation
A total of 1586 patients had a predicted probability of
delirium <0.30 with the E-PRE-DELIRIC model and
therefore were not deemed to be at high risk of delirium
based on the cutoff of 0.30. However, 262 of these pa-
tients eventually did experience delirium during their
ICU stay, despite an initial low predicted risk of delirium
calculated using the E-PRE-DELIRIC model. Using data
from the first 24 h in the ICU, the PRE-DELIRIC model
identified 64 of these 262 patients (24%) to be at high
risk of delirium (i.e. predicted probability of delirium ≥0.
30). The two-stage calculation improved the sensitivity
of the prediction by 14% compared to the E-PRE-
DELIRIC model alone and by 10% compared to the
PRE-DELIRIC model alone (Fig. 2).
User convenience
In total, 68 (41%) ICU physicians completed the user con-
venience questionnaire. Of the ICU physicians who partic-
ipated in this study 52 (76%) were intensivists, 11 (16%)
were intensivist trainees, 4 (6%) were specialists other than
intensivists, and 1 (2%) was a non-specialist physician.
There were 56 ICU physicians (82%) with no prior ex-
perience of using a delirium prediction model; only 1
physician had experience of using the E-PRE-DELIRIC
model and 11 of using the PRE-DELIRIC model: none
of the physicians used a prediction model regularly, al-
though 6 physicians (9%) stated that a prediction model
had been implemented in the ICU where they work.
Physicians perceived that the PRE-DELIRIC model
(versus the E-PRE-DELIRIC model) took more “time
and effort to collect data” (p < 0.05) and was a greater
“burden for the physician to collect the model data” (p
< 0.01). In contrast, for the E-PRE-DELIRIC model,
physicians perceived that “the predictors were more
available” (p < 0.05) and that they were more likely “to
use this model (vs. the PRE-DELIRIC model) in daily
practice” (p < 0.05). The “clearness of the definitions”
and the “reliability of the outcome” of the E-PRE-
Fig. 1 Study flowchart. E-PRE-DELIRIC, early prediction model for de-
lirium in ICU patients
Table 1 Patient characteristics
Variable Total cohort (N = 2178)
Age in years, mean (SD) 62.1 (15.2)
Male, N (%) 1324 (60.8)
Admission category, N (%)
-Surgery 1079 (49.5)
-Medical 859 (39.3)
-Trauma 86 (4.0)
-Neurology/neurosurgery 157 (7.2)
Urgent admission, N (%) 1345 (61.8)
Use of sedatives during ICU
stay for ≥ 1 day, N (%)
992 (45.5)
Comatose during ICU stay
for ≥ 1 day, N (%)
873 (40.1)
E-PRE-DELIRIC score, median
(Q1–Q3, min/max)
16.7 (9–32, 2/99)
PRE-DELIRIC score, median
(Q1–Q3, min/max)
18.4 (12–30, 3/98)
SOFA score, median
(Q1–Q3, min/max)
4.5 (3.0–6.6, 1/20)
APACHE-II score, mean (SD) 17.4 (7.1)
Delirium, N (%) 467 (21.4)
-Positive delirium assessment 431 (19.7)
-Positive based on
medication for delirium treatment
35 (1.7)
LOS-ICU in days, median
(Q1–Q3, min/max)
3.0 (2–6, 1/96)
Sedatives = IV sedative therapy. Level of sedation was assessed using either
the Richmond Agitation-Sedation Scale (RASS) or the Riker Sedation-Agitation
Scale (SAS) [21, 22]. Coma = RASS = − 4 or − 5 or Riker-SAS = 1 or 2
SOFA Sequential Organ Failure Assessment score [17], APACHE-II the Acute
Physiology and Chronic Health Evaluation II [16], LOS-ICU length of stay in the
intensive care unit, PRE-DELIRIC prediction model for delirium in ICU patients,
E-PRE-DELIRIC early prediction model for delirium in ICU patients
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DELIRIC and PRE-DELIRIC models were perceived to
be similar (Table 2 and Additional file 3: Table S2).
Quality check of the delirium assessment
The overall quality of delirium assessment and screening
compliance were strong (see Additional file 4: Table S3
for all IRR and compliance rates for each participating
ICU). When the ICUs that did not fully meet all delir-
ium assessment reliability criteria were removed from
the analysis, as was determined a priori, neither the
performance of the E-PRE-DELIRIC model nor the PRE-
DELIRIC model was significantly affected. Consequently
all centres were included in the primary analysis.
Discussion
This large, multinational prospective cohort study pro-
vides insight into the comparative performance of two
available ICU delirium prediction models (i.e. the E-
PRE-DELIRIC model that estimates the risk of delirium
at the time of ICU admission and the PRE-DELIRIC
model used to estimate the risk of delirium 24 h later)
[9–11]. Both models had a moderate-to-good statistical
performance. Although the predictive accuracy of the E-
PRE-DELIRIC model was somewhat lower, its user
convenience appeared to be better compared to the
PRE-DELIRIC model. To allow for optimal implementa-
tion of a delirium prediction model in daily practice, in-
volvement and the opinion on user convenience of the
target group, i.e. the ICU physicians, is very important
[28, 29]. Based on these results, the E-PRE-DELIRIC
model is likely the model that can be implemented most
successfully in daily ICU practice. Moreover, our analysis
indicates that when the E-PRE-DELIRIC model predicts
a low risk of delirium, an additional calculation using
the PRE-DELIRIC model after 24 h in the ICU increases
the model’s sensitivity to detect patients that will de-
velop delirium who are incorrectly identified as low-risk
patients. Thus, this method will prevent deprivation of
delirium-preventive measures in patients with a false
negative rating (i.e. the patients with predicted probabil-
ity <0.30 who develop delirium during ICU admission).
The routine use of delirium preventive measures in the
ICU is widely endorsed given the high prevalence of
Fig. 2 AUROC for the early prediction model for delirium in ICU patients (E-PRE-DELIRIC) and the prediction model for delirium in ICU
patients (PRE-DELIRIC)
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delirium, its deleterious effects on patient outcome [30, 31],
and the high costs related to these effects [32]. The routine
use of a delirium prediction model may facilitate early rec-
ognition of those patients at greatest risk of delirium who
may benefit the most from delirium preventive measures
[32]. Importantly, when resources are limited, the use of
delirium risk stratification to target high-risk patients
makes wider implementation of multicomponent non-
pharmacological interventions aimed at preventing
delirium more feasible [32]. Preventive measures should
be initiated as soon as possible after ICU admission; there-
fore an early ICU delirium prediction model is preferred.
The performance of a prediction model outside the de-
velopment sample determines its generalisability in clin-
ical practice [33]. External validation of many other
clinical prediction models is lacking [34]. Of interest, both
the E-PRE-DELIRIC and recalibrated PRE-DELIRIC
models are validated externally and had moderate-to-good
statistical performance in independent data sets, allowing
for generalisation to non-study ICUs around the world
[[35], Wassenaar et al. 2017]. “External validation of two
models to predict delirium in intensive care unit patients.
Unpublished data.” The delirium incidence, estimated
based on new positive delirium assessments after ICU
Table 2 Outcome user convenience questionnaire
Question Negative ranks^ (N) Ties^ (N) Positive ranks^ (N) Significance*
Time and effort needed to collect data to calculate
a patient’s risk
4 45 16 p < 0.05
Burden for the physician to collect data about the
predictors to calculate a patient’s risk
3 42 20 p < 0.01
Availability of predictors 11 50 4 p < 0.05
Clearness of the definitions of the predictors 5 56 4 p = 1.00
Reliability of the outcome (predicted risk) of the
prediction model
2 62 1 p > 0.5
Are you going to use the delirium prediction model
in daily practice?
9 55 1 p < 0.05
^Prediction model for delirium in ICU patients (PRE-DELIRIC) compared to the early prediction model for delirium in ICU patients (E-PRE-DELIRIC): negative ranks
indicate the number of ICU physicians who scored PRE-DELIRIC lower; ties indicate no difference; positive ranks indicate the number of ICU physicians who scored
PRE-DELIRIC higher
*Null hypotheses were tested against two-sided alternatives
Fig. 3 Calibration plot for the early prediction model for delirium in ICU patients (E-PRE-DELIRIC) and the prediction model for delirium in ICU
patients (PRE-DELIRIC)
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admission, is important for the performance and thus
the generalisation of both delirium prediction models.
One might argue that the delirium incidence in our
study cohort was relatively low. However, multiple
previous studies have reported comparable delirium
incidence rates [36–38].
Our study has important strengths. The use of a co-
hort design without strict eligibility criteria helped boost
its generalisability [14], and its prospective nature
allowed us to carefully measure and document the pre-
dictors and outcomes, thereby improving its applicability
and reproducibility in non-study ICUs [14, 20, 39]. The
large number of patients enrolled, their mixed character-
istics, and the multinational character of our study al-
lows the results to be applied in the vast majority of
ICUs in the developed world. Of note, when generalising
to high-intensity ICUs it should be taken into account
that their patient group will probably have more severe
illness in comparison with our study cohort. For future
research it might be of interest to study the performance
of both models in patients with APACHE and SOFA
scores in the higher ranges. The proportion of ICU phy-
sicians responding was better than response rates shown
in other physician surveys [40]. No imputation tech-
niques were used to handle missing data, as we wanted
to determine the clinical performance of both delirium
prediction models and the use of a prediction model in
daily clinical practice does not allow for imputation. Our
efforts to provide clear definitions and instruction man-
uals to all study sites resulted in the exclusion of only
fourteen patients due to missing values for the
predictors.
Several limitations are also present. It might be possible
that the two delirium prediction models evaluated might
need to be updated in the future as new risk factors for
delirium in the ICU may emerge. Of course, this also of-
fers an opportunity to further improve the discriminative
performance of each model, which in particular could
benefit the E-PRE-DELIRIC. For an update, referred to as
model revision, one needs to have insight into new risk
factors for delirium, both available at ICU admission or
within 24 h of ICU admission. Subsequently, a new pre-
diction study is needed to determine which of the new risk
factors improves the performance of the models and
should be used for model revision [41]. It is important to
realize that when a model is used to predict a patient’s risk
of an event, it should always be considered an approxima-
tion no matter how strong the documented predictive ac-
curacy. This is particularly important in the case of
medical decision making. Two well-validated delirium
screening-instruments (i.e. the CAM-ICU and the ICDSC)
were used in this study. Naturally, the sensitivity and spe-
cificity of each instrument differs [42]. Realizing that the
sensitivity of either screening tool is not 100%, we also
defined delirium to be present when haloperidol or an
atypical antipsychotic was administered for the treatment
of delirium. While each ICU had similar delirium treat-
ment protocols, we cannot exclude that antipsychotic
therapy may have been initiated in patients who did not
have delirium.
It is shown that ICU clinicians’ predictions are less ac-
curate than those of an ICU delirium prediction model
[9]. We believe that routine prognostic delirium evalu-
ation in the ICU is important in the clinical setting to
identify those patients who may benefit the most from
early preventive measures and in the research setting to
ensure that delirium risk is well-characterized and strati-
fied in controlled studies. We want to emphasize that
the predicted risk score is an estimation of the chance of
developing delirium during ICU admission that may fa-
cilitate early clinical decisions on delirium prevention
and personalized care to ICU patients and their family
members. However, the rationing of critical care resources
should not be based on the predicted risk score for delir-
ium over the first 24 h of ICU admission alone as the pre-
dicted risk score does not take into account changes in
the health status of ICU patients. For future controlled
studies on the effect of both non-pharmacological and
pharmacological interventions on ICU delirium, we sug-
gest stratifying patients based on their risk of delirium and
restricting delirium prevention to those patients at high
risk of delirium.
To achieve the best predictive performance and user
convenience currently possible, we suggest a two-stage
calculation using the E-PRE-DELIRIC model in all pa-
tients admitted to the ICU to predict patients’ risk of de-
lirium immediately after ICU admission and to update
the risk scores of the patients at low risk of delirium
after 24 h using the PRE-DELIRIC model. This way, the
chance of missing a patient that will develop delirium
during ICU admission is further attenuated. Still, a sub-
stantial minority of the patients that develop delirium
during ICU admission will score a low predicted risk for
delirium using both delirium prediction models in a
two-stage calculation. Of interest, in this study cohort
the delirium incidence was 21%. Based on the fact that
the sensitivity and specificity of a prediction model are
most optimal at the cutoff of the incidence level of the
outcome of interest, in this case delirium, we expect that
the sensitivity in a population with around 30% incidence
of delirium will be better compared to the sensitivity
shown in our study. Of importance, the acceptability of
the suggested two-stage calculation by ICU physicians is
not yet assessed. Future research should focus on the use-
fulness of both delirium prediction models in clinical
practice and their impact on clinical outcomes, since this
is the only way to determine whether their use improves
usual care [41]. In addition, such an impact analysis also
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provides the opportunity to study the acceptance of the
models in daily practice [41], in which it is interesting to
also take the experiences of ICU patients and their
families into account.
Conclusions
This study shows that statistically both ICU delirium
prediction models have moderate-to-good performance.
Although the predictive accuracy of the PRE-DELIRIC is
greater, the E-PRE-DELIRIC model scores significantly
better on user convenience. Moreover, the PRE-
DELIRIC model needs data obtained during a period of
24 h, while the E-PRE-DELIRIC can be obtained at ICU
admission, allowing direct preventive measures and
stratified randomization in studies at the time of ICU
admission. In patients who appear to be at low risk of
delirium at ICU admission, it is of additional advantage
to update their predicted risk scores using the PRE-
DELIRIC model after 24 h in the ICU.
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